Cargando…

Gastrointestinal Stromal Tumors, Somatic Mutations and Candidate Genetic Risk Variants

Gastrointestinal stromal tumors (GISTs) are rare but treatable soft tissue sarcomas. Nearly all GISTs have somatic mutations in either the KIT or PDGFRA gene, but there are no known inherited genetic risk factors. We assessed the relationship between KIT/PDGFRA mutations and select deletions or sing...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Brien, Katie M., Orlow, Irene, Antonescu, Cristina R., Ballman, Karla, McCall, Linda, DeMatteo, Ronald, Engel, Lawrence S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630216/
https://www.ncbi.nlm.nih.gov/pubmed/23637977
http://dx.doi.org/10.1371/journal.pone.0062119
_version_ 1782266679975215104
author O'Brien, Katie M.
Orlow, Irene
Antonescu, Cristina R.
Ballman, Karla
McCall, Linda
DeMatteo, Ronald
Engel, Lawrence S.
author_facet O'Brien, Katie M.
Orlow, Irene
Antonescu, Cristina R.
Ballman, Karla
McCall, Linda
DeMatteo, Ronald
Engel, Lawrence S.
author_sort O'Brien, Katie M.
collection PubMed
description Gastrointestinal stromal tumors (GISTs) are rare but treatable soft tissue sarcomas. Nearly all GISTs have somatic mutations in either the KIT or PDGFRA gene, but there are no known inherited genetic risk factors. We assessed the relationship between KIT/PDGFRA mutations and select deletions or single nucleotide polymorphisms (SNPs) in 279 participants from a clinical trial of adjuvant imatinib mesylate. Given previous evidence that certain susceptibility loci and carcinogens are associated with characteristic mutations, or “signatures” in other cancers, we hypothesized that the characteristic somatic mutations in the KIT and PDGFRA genes in GIST tumors may similarly be mutational signatures that are causally linked to specific mutagens or susceptibility loci. As previous epidemiologic studies suggest environmental risk factors such as dioxin and radiation exposure may be linked to sarcomas, we chose 208 variants in 39 candidate genes related to DNA repair and dioxin metabolism or response. We calculated adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the association between each variant and 7 categories of tumor mutation using logistic regression. We also evaluated gene-level effects using the sequence kernel association test (SKAT). Although none of the association p-values were statistically significant after adjustment for multiple comparisons, SNPs in CYP1B1 were strongly associated with KIT exon 11 codon 557-8 deletions (OR = 1.9, 95% CI: 1.3-2.9 for rs2855658 and OR = 1.8, 95% CI: 1.2-2.7 for rs1056836) and wild type GISTs (OR = 2.7, 95% CI: 1.5-4.8 for rs1800440 and OR = 0.5, 95% CI: 0.3-0.9 for rs1056836). CYP1B1 was also associated with these mutations categories in the SKAT analysis (p = 0.002 and p = 0.003, respectively). Other potential risk variants included GSTM1, RAD23B and ERCC2. This preliminary analysis of inherited genetic risk factors for GIST offers some clues about the disease's genetic origins and provides a starting point for future candidate gene or gene-environment research.
format Online
Article
Text
id pubmed-3630216
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36302162013-05-01 Gastrointestinal Stromal Tumors, Somatic Mutations and Candidate Genetic Risk Variants O'Brien, Katie M. Orlow, Irene Antonescu, Cristina R. Ballman, Karla McCall, Linda DeMatteo, Ronald Engel, Lawrence S. PLoS One Research Article Gastrointestinal stromal tumors (GISTs) are rare but treatable soft tissue sarcomas. Nearly all GISTs have somatic mutations in either the KIT or PDGFRA gene, but there are no known inherited genetic risk factors. We assessed the relationship between KIT/PDGFRA mutations and select deletions or single nucleotide polymorphisms (SNPs) in 279 participants from a clinical trial of adjuvant imatinib mesylate. Given previous evidence that certain susceptibility loci and carcinogens are associated with characteristic mutations, or “signatures” in other cancers, we hypothesized that the characteristic somatic mutations in the KIT and PDGFRA genes in GIST tumors may similarly be mutational signatures that are causally linked to specific mutagens or susceptibility loci. As previous epidemiologic studies suggest environmental risk factors such as dioxin and radiation exposure may be linked to sarcomas, we chose 208 variants in 39 candidate genes related to DNA repair and dioxin metabolism or response. We calculated adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the association between each variant and 7 categories of tumor mutation using logistic regression. We also evaluated gene-level effects using the sequence kernel association test (SKAT). Although none of the association p-values were statistically significant after adjustment for multiple comparisons, SNPs in CYP1B1 were strongly associated with KIT exon 11 codon 557-8 deletions (OR = 1.9, 95% CI: 1.3-2.9 for rs2855658 and OR = 1.8, 95% CI: 1.2-2.7 for rs1056836) and wild type GISTs (OR = 2.7, 95% CI: 1.5-4.8 for rs1800440 and OR = 0.5, 95% CI: 0.3-0.9 for rs1056836). CYP1B1 was also associated with these mutations categories in the SKAT analysis (p = 0.002 and p = 0.003, respectively). Other potential risk variants included GSTM1, RAD23B and ERCC2. This preliminary analysis of inherited genetic risk factors for GIST offers some clues about the disease's genetic origins and provides a starting point for future candidate gene or gene-environment research. Public Library of Science 2013-04-18 /pmc/articles/PMC3630216/ /pubmed/23637977 http://dx.doi.org/10.1371/journal.pone.0062119 Text en © 2013 O'Brien et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
O'Brien, Katie M.
Orlow, Irene
Antonescu, Cristina R.
Ballman, Karla
McCall, Linda
DeMatteo, Ronald
Engel, Lawrence S.
Gastrointestinal Stromal Tumors, Somatic Mutations and Candidate Genetic Risk Variants
title Gastrointestinal Stromal Tumors, Somatic Mutations and Candidate Genetic Risk Variants
title_full Gastrointestinal Stromal Tumors, Somatic Mutations and Candidate Genetic Risk Variants
title_fullStr Gastrointestinal Stromal Tumors, Somatic Mutations and Candidate Genetic Risk Variants
title_full_unstemmed Gastrointestinal Stromal Tumors, Somatic Mutations and Candidate Genetic Risk Variants
title_short Gastrointestinal Stromal Tumors, Somatic Mutations and Candidate Genetic Risk Variants
title_sort gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630216/
https://www.ncbi.nlm.nih.gov/pubmed/23637977
http://dx.doi.org/10.1371/journal.pone.0062119
work_keys_str_mv AT obrienkatiem gastrointestinalstromaltumorssomaticmutationsandcandidategeneticriskvariants
AT orlowirene gastrointestinalstromaltumorssomaticmutationsandcandidategeneticriskvariants
AT antonescucristinar gastrointestinalstromaltumorssomaticmutationsandcandidategeneticriskvariants
AT ballmankarla gastrointestinalstromaltumorssomaticmutationsandcandidategeneticriskvariants
AT mccalllinda gastrointestinalstromaltumorssomaticmutationsandcandidategeneticriskvariants
AT dematteoronald gastrointestinalstromaltumorssomaticmutationsandcandidategeneticriskvariants
AT engellawrences gastrointestinalstromaltumorssomaticmutationsandcandidategeneticriskvariants